Immunovant, Inc. (IMVT)
Immunovant Market Cap : 6.855B for Nov. 19, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 18, 2026 | 6.859B |
| November 17, 2026 | 6.867B |
| November 16, 2026 | 6.882B |
| November 13, 2026 | 7.068B |
| November 12, 2026 | 7.248B |
| November 11, 2026 | 7.659B |
| November 10, 2026 | 7.384B |
| November 09, 2026 | 7.269B |
| November 06, 2026 | 6.313B |
| November 05, 2026 | 5.871B |
| November 04, 2026 | 6.167B |
| November 03, 2026 | 5.990B |
| November 02, 2026 | 5.860B |
| October 30, 2026 | 6.017B |
| October 29, 2026 | 6.114B |
| October 28, 2026 | 6.068B |
| October 27, 2026 | 5.957B |
| October 26, 2026 | 5.810B |
| October 23, 2026 | 5.860B |
| October 22, 2026 | 6.002B |
| October 21, 2026 | 5.854B |
| October 20, 2026 | 5.897B |
| October 19, 2026 | 5.697B |
| October 16, 2026 | 5.513B |
| October 15, 2026 | 5.674B |
| Date | Value |
|---|---|
| October 14, 2026 | 5.755B |
| October 13, 2026 | 5.922B |
| October 12, 2026 | 6.081B |
| October 09, 2026 | 6.285B |
| October 08, 2026 | 6.242B |
| October 07, 2026 | 6.609B |
| October 06, 2026 | 6.623B |
| October 05, 2026 | 6.858B |
| October 02, 2026 | 6.935B |
| October 01, 2026 | 6.941B |
| September 30, 2026 | 6.968B |
| September 29, 2026 | 6.902B |
| September 28, 2026 | 6.908B |
| September 25, 2026 | 6.869B |
| September 24, 2026 | 7.013B |
| September 23, 2026 | 7.124B |
| September 22, 2026 | 7.692B |
| September 21, 2026 | 7.669B |
| September 18, 2026 | 7.621B |
| September 17, 2026 | 7.766B |
| September 16, 2026 | 7.504B |
| September 15, 2026 | 7.560B |
| September 14, 2026 | 7.768B |
| September 11, 2026 | 7.706B |
| September 10, 2026 | 7.859B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Roivant Sciences Ltd. | 28.25B |
| Ionis Pharmaceuticals, Inc. | 4.540B |
| Vertex Pharmaceuticals, Inc. | 134.40B |
| Heron Therapeutics, Inc. | 49.30M |
| TG Therapeutics, Inc. | 10.01B |
Market Cap Related Metrics
| Price to Book Value | 10.43 |
| Price | 33.15 |
| Earnings Yield | -7.70% |